- Home
- ZKIN vs BIAF Comparison
ZKIN vs BIAF Comparison
Compare ZKIN & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZKIN
- BIAF
- Stock Information
- Founded
- ZKIN 2015
- BIAF 2014
- Country
- ZKIN China
- BIAF United States
- Employees
- ZKIN N/A
- BIAF N/A
- Industry
- ZKIN Metal Fabrications
- BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- ZKIN Industrials
- BIAF Health Care
- Exchange
- ZKIN Nasdaq
- BIAF Nasdaq
- Market Cap
- ZKIN 10.3M
- BIAF 12.2M
- IPO Year
- ZKIN 2017
- BIAF 2022
- Fundamental
- Price
- ZKIN $2.54
- BIAF $0.35
- Analyst Decision
- ZKIN
- BIAF Hold
- Analyst Count
- ZKIN 0
- BIAF 1
- Target Price
- ZKIN N/A
- BIAF N/A
- AVG Volume (30 Days)
- ZKIN 182.5K
- BIAF 12.3M
- Earning Date
- ZKIN 01-27-2025
- BIAF 08-13-2025
- Dividend Yield
- ZKIN N/A
- BIAF N/A
- EPS Growth
- ZKIN N/A
- BIAF N/A
- EPS
- ZKIN N/A
- BIAF N/A
- Revenue
- ZKIN $108,199,877.00
- BIAF $8,809,228.00
- Revenue This Year
- ZKIN N/A
- BIAF N/A
- Revenue Next Year
- ZKIN N/A
- BIAF $20.00
- P/E Ratio
- ZKIN N/A
- BIAF N/A
- Revenue Growth
- ZKIN N/A
- BIAF 78.40
- 52 Week Low
- ZKIN $0.82
- BIAF $0.16
- 52 Week High
- ZKIN $6.30
- BIAF $2.99
- Technical
- Relative Strength Index (RSI)
- ZKIN 55.69
- BIAF 56.50
- Support Level
- ZKIN $2.31
- BIAF $0.27
- Resistance Level
- ZKIN $3.41
- BIAF $0.38
- Average True Range (ATR)
- ZKIN 0.34
- BIAF 0.04
- MACD
- ZKIN 0.05
- BIAF 0.01
- Stochastic Oscillator
- ZKIN 43.87
- BIAF 76.26
About ZKIN ZK International Group Co. Ltd
ZK International Group Co Ltd is engaged in the manufacture and marketing of metal pipes. The company is specialized in producing double-press thin-walled stainless steel tubes and fittings, carbon steel tubes and fittings, single-press tubes and fittings, and stainless-steel strips. The products are used in restaurants, hotels, hospitals, firefighting, food, beverage, ships, engines, industrial seawater desalination and systems of direct-drinking water, cold /hot water supply, city water supply, and gas of large/middle scale construction projects.
About BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.